Duration of Cryopreservation of Third-Party Viral Specific T-Cells (TP-VSTs) Does Not Influence Clinical Efficacy

Key Points

• Clinical efficacy is unaffected by varying cryopreservation durations, indicating consistency in treatment outcomes.
• No specific metrics regarding efficacy were mentioned, suggesting qualitative assessments may be in use.
• Analysis of third-party viral specific T-cells involved various preservation timeframes to explore potential impacts.
• Findings suggest broader applicability of T-cell therapies, highlighting the potential for maintaining efficacy regardless of storage length.